Home
About Us
Subject
Browse
0
Sign In
Biological therapies
Biological Therapies or Apremilast in the Treatment of Psoriasis in Patients with a History of Hematologic Malignancy: Results from a Retrospective Study in 21 Patients
Article
Year: 2021
Pages: 10
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Osteoporosis: Current and Emerging Therapies Targeted to Immunological Checkpoints
Article
Pages: 17
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Sublingual Bacterial Vaccination Reduces Recurrent Infections in Patients With Autoimmune Diseases Under Immunosuppressant Treatment
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
RIPK1-Associated Inborn Errors of Innate Immunity
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Effect of different cryopreservation media on human nucleus pulposus cells' viability and trilineage potential
Article
Year: 2021
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Secukinumab provides sustained low rates of radiographic progression in psoriatic arthritis: 52-week results from a phase 3 study, FUTURE 5
Article
Year: 2019
Pages: 10
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Impact of tapering targeted therapies (bDMARDs or JAKis) on the risk of serious infections and adverse events of special interest in patients with rheumatoid arthritis or spondyloarthritis: a systematic analysis of the literature and meta-analysis
Article
Year: 2020
Pages: 1
Share
Facebook
Twitter
Linkedin
Whatsapp
More Info
Load More
More Info